These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36251411)

  • 1. Integrative transcriptome analysis reveals TEKT2 and PIAS2 involvement in diabetic nephropathy.
    Li Y; Lin H; Shu S; Sun Y; Lai W; Chen W; Hu Z; Peng H
    FASEB J; 2022 Nov; 36(11):e22592. PubMed ID: 36251411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq.
    Wang Y; Niu A; Pan Y; Cao S; Terker AS; Wang S; Fan X; Toth CL; Ramirez Solano MA; Michell DL; Contreras D; Allen RM; Zhu W; Sheng Q; Fogo AB; Vickers KC; Zhang MZ; Harris RC
    Diabetes; 2021 Oct; 70(10):2377-2390. PubMed ID: 34233930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
    J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
    [No Abstract]   [Full Text] [Related]  

  • 4. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
    Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
    Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin is down-regulated in diabetic kidney glomeruli and regulates actin reorganization and glucose uptake via GLUT1 in cultured podocytes.
    Wasik AA; Koskelainen S; Hyvönen ME; Musante L; Lehtonen E; Koskenniemi K; Tienari J; Vaheri A; Kerjaschki D; Szalay C; Révész C; Varmanen P; Nyman TA; Hamar P; Holthöfer H; Lehtonen S
    Am J Pathol; 2014 Jun; 184(6):1727-39. PubMed ID: 24726496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 8. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
    Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease.
    Fu J; Akat KM; Sun Z; Zhang W; Schlondorff D; Liu Z; Tuschl T; Lee K; He JC
    J Am Soc Nephrol; 2019 Apr; 30(4):533-545. PubMed ID: 30846559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPBP as a marker of diabetic nephropathy podocyte injury via Bioinformatics Analysis.
    Zhang F; Jiang N; Gao Y; Fan Z; Li Q; Ke G; Li B; Wu Q; Xu R; Liu S
    Biochem Biophys Res Commun; 2021 Nov; 577():165-172. PubMed ID: 34555684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
    Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
    Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of PDK4 as Hub Gene for Diabetic Nephropathy Using Co-Expression Network Analysis.
    Han Y; Jin L; Wang L; Wei L; Tu C
    Kidney Blood Press Res; 2023; 48(1):522-534. PubMed ID: 37385224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term expression of glomerular genes in diabetic nephropathy.
    Chittka D; Banas B; Lennartz L; Putz FJ; Eidenschink K; Beck S; Stempfl T; Moehle C; Reichelt-Wurm S; Banas MC
    Nephrol Dial Transplant; 2018 Sep; 33(9):1533-1544. PubMed ID: 29340699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
    Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
    Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.
    Lee HS; Suh JY; Kang BC; Lee E
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F548-F558. PubMed ID: 33586497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
    Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
    Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy.
    Li MR; Lei CT; Tang H; Yin XJ; Hao Z; Qiu Y; Xie YR; Zeng JY; Su H; Zhang C
    Int J Biol Sci; 2022; 18(5):1896-1911. PubMed ID: 35342338
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Glomerular and Podocyte mRNA Profiles in Streptozotocin-Induced Diabetes.
    Fu J; Wei C; Lee K; Zhang W; He W; Chuang P; Liu Z; He JC
    J Am Soc Nephrol; 2016 Apr; 27(4):1006-14. PubMed ID: 26264855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased dishevelled associated activator of morphogenesis 2, a new podocyte-associated protein, in diabetic nephropathy.
    Qi C; Alsomali F; Zhong J; Harris RC; Kon V; Yang H; Fogo AB
    Nephrol Dial Transplant; 2021 May; 36(6):1006-1016. PubMed ID: 33544843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.